Post Translational Modification

Introduction

Post translational modification (PTM) denotes covalent and generally enzymatic modification of proteins following translation. PTMs diversify proteome complexity beyond genomic coding capacity. They modulate protein folding, activity, stability, localization, and interactions. PTMs constitute a rapid and reversible cellular regulation layer crucial in signaling and homeostasis.

"Proteins are not just chains of amino acids; their functional destiny is largely determined by the molecular decorations they acquire after synthesis." -- Dr. C. Walsh

Definition and Overview

What is Post Translational Modification?

PTM: chemical alteration of a protein after ribosomal synthesis. Modifications include addition/removal of functional groups, proteolytic cleavage, or structural rearrangement. Occurs in cytosol, ER, Golgi, nucleus.

Significance

Proteome complexity: PTMs increase functional diversity. Regulation: modulate enzymatic activity, interaction networks. Localization: target proteins to organelles/membranes. Stability: influence degradation rates.

Classification

Reversible PTMs: phosphorylation, acetylation, methylation, ubiquitination. Irreversible PTMs: proteolytic cleavage, disulfide bond formation.

Types of Post Translational Modifications

Phosphorylation

Addition of phosphate group mainly to serine, threonine, tyrosine residues. Regulates activity, signaling cascades.

Glycosylation

Covalent attachment of carbohydrates to asparagine (N-linked) or serine/threonine (O-linked). Affects folding, stability, cell recognition.

Ubiquitination

Attachment of ubiquitin to lysine residues. Tags proteins for degradation or alters cellular localization.

Methylation and Acetylation

Methyl groups added to lysine/arginine; acetyl groups added to lysine. Modulate chromatin structure, transcription factor activity.

Lipidation

Attachment of lipid moieties (e.g., palmitoylation, prenylation). Directs membrane association.

Proteolytic Cleavage

Specific peptide bond hydrolysis activating or inactivating proteins (e.g., zymogens).

Sumoylation and Other Modifications

Small ubiquitin-like modifier (SUMO) conjugation involved in nuclear transport, transcriptional regulation.

Mechanisms of Post Translational Modifications

Enzymatic Catalysis

PTMs typically catalyzed by specific enzymes: kinases, transferases, proteases. Enzymes recognize consensus motifs or structural contexts.

Cofactors and Substrates

Phosphate donors (ATP), acetyl donors (acetyl-CoA), methyl donors (SAM) required. Availability regulates PTM rates.

Reversibility

Phosphatases, deacetylases, demethylases remove modifications, enabling dynamic regulation.

Proteolytic Processing

Irreversible cleavage by proteases activates/inactivates proteins or generates functional fragments.

Subcellular Localization

PTM enzymes localize in specific compartments, influencing modification patterns.

Example: Kinase-mediated phosphorylation1. Substrate recognition via consensus motif2. ATP binding in kinase active site3. Transfer of γ-phosphate to hydroxyl group on Ser/Thr/Tyr4. Conformational change in substrate alters activity

Functional Consequences

Activity Regulation

PTMs induce conformational shifts activating or inhibiting enzymatic functions.

Protein-Protein Interactions

Modified residues serve as docking sites for interaction domains (e.g., SH2 domains recognize phosphotyrosines).

Subcellular Targeting

Lipidation directs membrane association; nuclear localization signals exposed by cleavage or phosphorylation.

Protein Stability

Ubiquitination marks proteins for degradation via proteasome; acetylation can shield from degradation.

Signaling Cascades

PTMs propagate or modulate intracellular signaling pathways rapidly and reversibly.

Enzymes Involved in PTMs

Kinases and Phosphatases

Kinases: transfer phosphate groups. Phosphatases: remove phosphate groups. Balance controls phosphorylation states.

Transferases

Acetyltransferases, methyltransferases, glycosyltransferases catalyze addition of acetyl, methyl, or sugar moieties.

Proteases

Specific cleavage enzymes activate/inactivate proteins, e.g., caspases in apoptosis.

Ubiquitin Ligases and Deubiquitinases

Attach or remove ubiquitin. Regulate protein turnover and signaling.

SUMO Ligases

Conjugate SUMO proteins modifying nuclear transport, transcriptional activity.

Methods for Detection and Analysis

Mass Spectrometry

High-resolution detection of PTMs. Identifies modification sites, stoichiometry.

Western Blotting with PTM-specific Antibodies

Detects presence and dynamics of specific PTMs.

Chromatographic Techniques

Enrichment of modified peptides (e.g., IMAC for phosphopeptides).

Fluorescence and Imaging

Fluorescent probes or antibodies visualize PTMs in situ.

Computational Prediction

Bioinformatics tools predict PTM sites from sequence and structural data.

PTMs in Cell Signaling

Signal Transduction

Phosphorylation cascades regulate kinase activation, transcription factor activity.

Receptor Regulation

Ubiquitination modulates receptor internalization and degradation.

Second Messenger Systems

PTMs alter enzymes generating cAMP, IP3, enabling rapid responses.

Feedback Mechanisms

PTMs serve as molecular switches creating positive/negative feedback loops.

Cross-talk

Multiple PTMs on same protein modulate signaling specificity and intensity.

PTMs and Disease

Cancer

Aberrant phosphorylation, acetylation alter oncogene/tumor suppressor function.

Neurodegenerative Diseases

Hyperphosphorylation of tau, ubiquitin accumulation in Alzheimer’s, Parkinson’s.

Metabolic Disorders

Defects in glycosylation affect insulin receptor function, causing diabetes.

Infectious Diseases

Pathogens exploit host PTMs to evade immune response.

Congenital Disorders

Mutations impairing PTM enzymes cause inherited syndromes.

PTMs in Protein Degradation

Ubiquitin-Proteasome System

Polyubiquitination targets proteins for 26S proteasome degradation.

Autophagy

PTMs label proteins/organelles for lysosomal degradation.

Sumoylation Effects

Sumoylation can protect proteins from ubiquitin-mediated degradation.

Degradation Signals (Degrons)

PTMs create or mask degrons, determining protein half-life.

Proteolytic Cleavage

Cleavage removes inhibitory domains, tags proteins for turnover.

Regulation of PTMs

Enzyme Expression Levels

Transcriptional control of modifying enzymes alters PTM landscape.

Substrate Availability

Protein conformation and localization determine accessibility.

Feedback Loops

PTMs can regulate their own modifying enzymes.

Cell Cycle and Environmental Signals

Dynamic PTM changes coordinate cellular responses to stimuli.

Compartmentalization

Spatial segregation of enzymes and substrates controls PTM specificity.

Applications and Biotechnological Use

Therapeutic Targets

Kinase inhibitors in cancer therapy. Modulators of ubiquitination in neurodegeneration.

Protein Engineering

Design of proteins with tailored PTMs for enhanced stability or function.

Biomarker Discovery

PTM profiles as diagnostic and prognostic indicators.

Drug Development

Screening compounds affecting PTM enzymes.

Industrial Enzymes

PTMs optimize enzyme properties for industrial applications.

Workflow for PTM-targeted drug discovery:1. Identify disease-associated PTM enzyme2. Screen compound libraries for inhibitors/activators3. Validate effect on PTM and downstream signaling4. Optimize lead compounds for potency and specificity5. Clinical trials to test efficacy and safety

References

• Walsh, C.T., Garneau-Tsodikova, S., Gatto, G.J. Jr., "Protein posttranslational modifications: the chemistry of proteome diversifications," Angew. Chem. Int. Ed., 44(45), 2005, 7342–7372.
• Jensen, O.N., "Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry," Curr. Opin. Chem. Biol., 8(1), 2004, 33–41.
• Hunter, T., "Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling," Cell, 80(2), 1995, 225–236.
• Hershko, A., Ciechanover, A., "The ubiquitin system," Annu. Rev. Biochem., 67, 1998, 425–479.
• Deribe, Y.L., Pawson, T., Dikic, I., "Post-translational modifications in signal integration," Nat. Struct. Mol. Biol., 17(6), 2010, 666–672.